Progyny Inc (NASDAQ:PGNY) saw an uptick in trading volume on Wednesday . 1,594,593 shares traded hands during trading, an increase of 124% from the previous session’s volume of 712,996 shares.The stock last traded at $34.28 and had previously closed at $30.96.

Several brokerages have recently weighed in on PGNY. Leerink Swann began coverage on shares of Progyny in a research report on Wednesday, November 27th. They set an “outperform” rating and a $28.00 price objective for the company. Piper Jaffray Companies began coverage on shares of Progyny in a research report on Wednesday, November 27th. They set an “overweight” rating and a $33.00 price objective for the company. Citigroup began coverage on shares of Progyny in a research report on Wednesday, November 27th. They set a “buy” rating and a $30.00 price objective for the company. JPMorgan Chase & Co. began coverage on shares of Progyny in a research report on Wednesday, November 27th. They set an “overweight” rating and a $26.00 price objective for the company. Finally, Svb Leerink began coverage on shares of Progyny in a research report on Tuesday, November 19th. They set an “outperform” rating and a $28.00 price objective for the company. Six investment analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus target price of $29.67.

The firm has a 50-day moving average of $29.70.

Progyny (NASDAQ:PGNY) last issued its quarterly earnings data on Wednesday, December 4th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $61.20 million for the quarter, compared to analysts’ expectations of $60.83 million. The business’s revenue was up 120.1% on a year-over-year basis. On average, sell-side analysts predict that Progyny Inc will post 0.11 earnings per share for the current year.

Hedge funds have recently added to or reduced their stakes in the stock. Advisor Group Inc. purchased a new stake in Progyny in the 4th quarter valued at $39,000. Bank of Montreal Can purchased a new stake in Progyny in the 4th quarter valued at $40,000. Victory Capital Management Inc. purchased a new stake in Progyny in the 4th quarter valued at $50,000. Citigroup Inc. purchased a new stake in Progyny in the 4th quarter valued at $64,000. Finally, Strs Ohio purchased a new stake in Progyny in the 4th quarter valued at $82,000.

About Progyny (NASDAQ:PGNY)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

See Also: Diluted Earnings Per Share

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.